(AA) Alcoa trading up 2% on hopes that the Alcan rebuff will put into play.
(AL) Alcan denied the Alcoa takeover attempt as “insufficient” and shares up over 3% on hopes for a higher bid.
(AEZS) AEterna Zentaris showed some positive data via a partner presentation at AUA conference.
(BOOM) Dynamic Materials received an $8.3M order for explosion wielded plates.
(CEI) Crescent being acquired by Morgan Stanley.
(DJ) Dow Jones’ Bancroft family is now getting together to discuss the News Corp. offer.
(DDS) Dillard’s $0.53 EPS vs $0.72e, unsure if comparable.
(EVST) Everlast will launch new global brand and product strategy to build on its status.
(HPQ) Hewlett-Packard wins NASA contract valued at potentially more than $5 Billion.
(KBH) KB Home enetered into sale of French home unit, had already been partially disclosed.
(MDT) Medtronic trading up 4% after beating earnings.
(MER) Merrill Lynch is reportedly set for a restructuring.
(MMR) McMoran Exploration noted favorably as a leveraged energy wildcatter.
(NFLD) Northfield Labs said Phase III PolyHeme was not statistically significant.
(NVT) Navteq received a mapping contract from BMW.
(OMCL) Omnicell priced a 3.9M share secondary at $21.50 per share.
(SRR) Stride Rite gets a $20.50 buyout offer from Payless Shoes.
(TLB) Talbots $0.10 EPS vs $0.09e.
(VICL) Vical’s patented Vaxfectin delivered by needle-free injection yielded significantly higher antibody responses than an unformulated DNA vaccine delivered by needle and syringe.
(WTSLA) wet Seal $0.07 EPS vs $0.06e.
Jon C. Ogg
May 23, 2007